Liber Pharmaceuticals’ statement on ingredient safety and device design of its Nicovape Q products
Pharmacy Practice Notice Published on 10 March 2026 Liber Pharmaceuticals’ statement on ingredient...
Pharmacists
Pharmacy practice notice: Transition to Nicovape® Q2 System Complete
Pharmacy Practice Notice Published on 9 January 2025 Transition to Nicovape® Q2 System...
Pharmacy practice notice: Scheduling of NVPs in Western Australia
Pharmacy Practice Notice Published on 22 November 2024 Scheduling of NVPs in Western...
Understanding the current vaping laws
Pharmacist Information Hub Understanding the current vaping laws Pharmacists have dispensed vaping products...
The scientific consensus on vaping
Pharmacist Information Hub The scientific consensus on vaping The gold standard for understanding...
The role of therapeutic vaping in pharmacy
Pharmacist Information Hub The role of therapeutic vaping in pharmacy Pharmacists are the...
How to assess patients and supply S3 vapes
Pharmacist Information Hub How to assess patients and supply S3 vapes Patients seeking...
Checklist: supplying S3 vapes
Pharmacist Information Hub Checklist: Supplying S3 vapes Checklist: Supplying S3 vapes Step-by-step checklist...
How to dispense S4 vapes
Pharmacist Information Hub How to dispense S4 therapeutic vapes Understanding the prescribing pathways...